Baxiva Company
Baxiva is an emerging biotechnology startup focused on the development of next-generation glycoconjugate vaccines designed to prevent and combat bacterial infections. By leveraging advanced glycoengineering technologies and innovative vaccine platforms, Baxiva aims to create more effective and longer-lasting immunizations that address both existing and emerging bacterial threats.
Headquarters:
Schlieren, Zurich, Switzerland, Europe
Founded Date:
2025-01-01
Industry:
Vaccines & Immunotherapy
Employee Number:
1-10
Super Industry:
Biopharma & Life Science Tools
Investors:
CARB-X, Venture Kick
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland